|
Market Closed -
Nasdaq
04:00:00 2025-10-06 pm EDT
|
5-day change | 1st Jan Change | ||
| 5.670 USD | -.--% |
|
-.--% | - |
| 25-10-07 | MannKind Corporation completed the acquisition of scPharmaceuticals Inc.. | CI |
| 25-10-07 | MannKind Completes Acquisition of scPharmaceuticals | MT |
| Market Cap | 305M 262M 247M 225M 422M 28.78B 423M 2.92B 1.13B 14.77B 1.14B 1.12B 47.57B | P/E 2027 * |
-
| P/E 2028 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 281M 242M 227M 208M 389M 26.52B 390M 2.69B 1.04B 13.6B 1.05B 1.03B 43.83B | EV / Sales 2027 * |
-
| EV / Sales 2028 * | - |
| Free-Float |
98.42% | Yield 2027 * |
-
| Yield 2028 * | - |
Last Transcript : scPharmaceuticals Inc.
| 1 year | 5.57 |  | 5.7 |
| 3 years | 1.94 | | 7.7 |
| 5 years | 1.94 | | 12.75 |
| 10 years | 1.94 | | 18.17 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Castagna
CEO | Chief Executive Officer | 49 | 2025-10-06 |
| Director of Finance/CFO | 50 | 2025-10-06 | |
David Thomson
SEC | Corporate Secretary | 59 | 2025-10-06 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Castagna
BRD | Director/Board Member | 49 | 2025-10-06 |
David Thomson
BRD | Director/Board Member | 59 | 2025-10-06 |
| Director/Board Member | 50 | 2025-10-06 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/7/25 | Tender | Chairman | 77,174 | 0.1542% | ||
| 10/7/25 | Tender | Director | 177,950 | 0.3556% | ||
| 10/7/25 | Issuer sale | Director | 72,174 | 0.1442% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | +1.61% | -24.10% | 305M | |
| -0.88% | -2.15% | +54.71% | +106.31% | 1,034B | |
| -1.15% | +2.68% | +53.97% | +71.50% | 671B | |
| -1.44% | +0.38% | +20.40% | +73.05% | 460B | |
| +0.14% | -0.47% | +29.49% | +38.56% | 353B | |
| -1.33% | +4.72% | +24.69% | +45.55% | 309B | |
| -1.15% | +0.30% | -1.49% | +12.31% | 255B | |
| -1.55% | +1.11% | +56.10% | +70.32% | 240B | |
| -0.88% | +1.15% | -17.09% | -54.39% | 207B | |
| -0.15% | +3.65% | +33.90% | +96.99% | 188B | |
| Average | -0.89% | +0.99% | +25.63% | +43.61% | 371.71B | |
| Weighted average by Cap. | -1.10% | +0.51% | +36.61% | +66.20% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | - | - |
| Net income | - | - |
| Net Debt | - | - |
Employees
163
Sector
Pharmaceuticals
- Stock Market
- Stocks
- SCPH Stock
Select your edition
All financial news and data tailored to specific country editions
